Activation of the ghrelin receptor is described by a privileged collective motion: a model for constitutive and agonist-induced activation of a sub-class A G-protein coupled receptor (GPCR).

Three homology models of the human ghrelin receptor (GHS-R1a) have been generated from the available X-ray structures of rhodopsin (RHO model), opsin (OPS model) and beta-2 adrenergic receptor (B2 model). The latter was used as a starting point for combined molecular dynamics simulation (MDS) and full atom normal modes analysis (NMA). A low-frequency normal mode (mode 16) perfectly reproduced the intracellular motions observed between B2 and RHO models; in the opposite direction along the same mode, the generated structures are closer to the OPS model, suggesting a direct link with GHS-R1a activation. This was in agreement with motions of the seven transmembranous segments, increase of the solvent accessibility of the 140-ERY-142 sequence, and flip of the Trp276 (C WLP) residue, some features related to GPCRs activation. According to our model, His280 was proposed to stabilize Trp276 in the active state; this was verified by site-directed mutagenesis and biochemical characterization of the resulting H280A and H280S mutants, which were fully functional but sharing an important decrease of their basal activities. Docking performed with short ghrelin derivatives Gly-Ser-Ser ([octa])-Phe-NH (2) and Gly-Ser-Ser ([octa])-Phe-Leu-NH (2) allowed the identification of a robust position of these peptides in the active site of the receptor. This model was refined by MDS and validated by docking experiments performed on a set of 55 ghrelin receptor ligands based on the 1,2,4- triazole scaffold. Finally, NMA performed on the obtained peptide-receptor complex suggested stabilization of the Trp276 residue and of the whole receptor in the active state, preventing the motion observed along mode 16 computed for the unbound receptor. Our results show that NMA offers a powerful approach to study the conformational diversity and the activation mechanism of GPCRs.

[1]  T. Darden,et al.  Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .

[2]  Alessandro Pedretti,et al.  Structure and dynamics of the full-length M1 muscarinic acetylcholine receptor studied by molecular dynamics simulations. , 2008, Archives of biochemistry and biophysics.

[3]  David Pérahia,et al.  Computation of Low-frequency Normal Modes in Macromolecules: Improvements to the Method of Diagonalization in a Mixed Basis and Application to Hemoglobin , 1995, Comput. Chem..

[4]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .

[5]  T. Blundell,et al.  Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.

[6]  J. Fortin,et al.  Four Missense Mutations in the Ghrelin Receptor Result in Distinct Pharmacological Abnormalities , 2007, Journal of Pharmacology and Experimental Therapeutics.

[7]  S. Rasmussen,et al.  The structure and function of G-protein-coupled receptors , 2009, Nature.

[8]  Richard D. Taylor,et al.  Improved protein–ligand docking using GOLD , 2003, Proteins.

[9]  A. Hirshfeld,et al.  Coupling of retinal isomerization to the activation of rhodopsin. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Viktor Hornak,et al.  Location of Trp265 in metarhodopsin II: implications for the activation mechanism of the visual receptor rhodopsin. , 2006, Journal of molecular biology.

[11]  E. Marco,et al.  Mechanism of Activation of a G Protein-coupled Receptor, the Human Cholecystokinin-2 Receptor* , 2007, Journal of Biological Chemistry.

[12]  D. Pérahia,et al.  Normal mode analysis as a prerequisite for drug design: Application to matrix metalloproteinases inhibitors , 2006, FEBS letters.

[13]  J. Thompson,et al.  The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. , 1997, Nucleic acids research.

[14]  J. Klein-Seetharaman,et al.  Structural features and light-dependent changes in the sequence 59-75 connecting helices I and II in rhodopsin: a site-directed spin-labeling study. , 1999, Biochemistry.

[15]  Thomas Huber,et al.  Functional role of the "ionic lock"--an interhelical hydrogen-bond network in family A heptahelical receptors. , 2008, Journal of molecular biology.

[16]  Claudio N. Cavasotto,et al.  Discovery of novel chemotypes to a G-protein-coupled receptor through ligand-steered homology modeling and structure-based virtual screening. , 2008, Journal of medicinal chemistry.

[17]  Nagarajan Vaidehi,et al.  Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors. , 2008, Journal of molecular biology.

[18]  Bernard Maigret,et al.  Collective motions in glucosamine-6-phosphate synthase: influence of ligand binding and role in ammonia channelling and opening of the fructose-6-phosphate binding site. , 2009, Journal of molecular biology.

[19]  C. Fisher,et al.  Modification of a PCR-based site-directed mutagenesis method. , 1997, BioTechniques.

[20]  M. Struthers,et al.  G protein-coupled receptor activation: analysis of a highly constrained, "straitjacketed" rhodopsin. , 2000, Biochemistry.

[21]  Patrick R. Griffin,et al.  A Receptor in Pituitary and Hypothalamus That Functions in Growth Hormone Release , 1996, Science.

[22]  J. Pantel,et al.  Loss of constitutive activity of the growth hormone secretagogue receptor in familial short stature. , 2006, The Journal of clinical investigation.

[23]  V. Locatelli,et al.  Toward potent ghrelin receptor ligands based on trisubstituted 1,2,4-triazole structure. 2. Synthesis and pharmacological in vitro and in vivo evaluations. , 2007, Journal of medicinal chemistry.

[24]  A. Moulin,et al.  Recent Developments in Ghrelin Receptor Ligands , 2007, ChemMedChem.

[25]  V. Locatelli,et al.  New active series of growth hormone secretagogues. , 2003, Journal of Medicinal Chemistry.

[26]  Julian Tirado-Rives,et al.  Contribution of conformer focusing to the uncertainty in predicting free energies for protein-ligand binding. , 2006, Journal of medicinal chemistry.

[27]  Xavier Deupi,et al.  Conformational complexity of G-protein-coupled receptors. , 2007, Trends in pharmacological sciences.

[28]  M. Karplus,et al.  CHARMM: A program for macromolecular energy, minimization, and dynamics calculations , 1983 .

[29]  Gerhard Hummer,et al.  Atomistic insights into rhodopsin activation from a dynamic model. , 2008, Journal of the American Chemical Society.

[30]  A. Clayton,et al.  Tryptophan rotamer distributions in amphipathic peptides at a lipid surface. , 1999, Biophysical journal.

[31]  J. Ballesteros,et al.  Beta2 adrenergic receptor activation. Modulation of the proline kink in transmembrane 6 by a rotamer toggle switch. , 2002, The Journal of biological chemistry.

[32]  K Schulten,et al.  VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.

[33]  H Weinstein,et al.  Functional role of a conserved motif in TM6 of the rat mu opioid receptor: constitutively active and inactive receptors result from substitutions of Thr6.34(279) with Lys and Asp. , 2001, Biochemistry.

[34]  M. Nakazato,et al.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach , 1999, Nature.

[35]  O. Lichtarge,et al.  Similar structures and shared switch mechanisms of the beta2-adrenoceptor and the parathyroid hormone receptor. Zn(II) bridges between helices III and VI block activation. , 1999, The Journal of biological chemistry.

[36]  J. Drews.  Drug discovery: a historical perspective. , 2000, Science.

[37]  D. Pérahia,et al.  Human thrombospondin's (TSP-1) C-terminal domain opens to interact with the CD-47 receptor: a molecular modeling study. , 2008, Archives of biochemistry and biophysics.

[38]  Laxmikant V. Kalé,et al.  Scalable molecular dynamics with NAMD , 2005, J. Comput. Chem..

[39]  Manuel Dauchez,et al.  Structural characterization of VGVAPG, an elastin-derived peptide. , 2004, Biopolymers.

[40]  Claudio N. Cavasotto,et al.  Protein flexibility in ligand docking and virtual screening to protein kinases. , 2004, Journal of molecular biology.

[41]  H. Khorana,et al.  Requirement of Rigid-Body Motion of Transmembrane Helices for Light Activation of Rhodopsin , 1996, Science.

[42]  N. Grishin,et al.  Identification of the Acyltransferase that Octanoylates Ghrelin, an Appetite-Stimulating Peptide Hormone , 2008, Cell.

[43]  Alexander D. MacKerell,et al.  All-atom empirical potential for molecular modeling and dynamics studies of proteins. , 1998, The journal of physical chemistry. B.

[44]  Marta Filizola,et al.  Modeling activated states of GPCRs: the rhodopsin template , 2006, J. Comput. Aided Mol. Des..

[45]  Jeremy C. Smith,et al.  Conformational heterogeneity and low-frequency vibrational modes of proteins. , 2006, Physical chemistry chemical physics : PCCP.

[46]  Christophe Chipot,et al.  Probing a model of a GPCR/ligand complex in an explicit membrane environment: the human cholecystokinin-1 receptor. , 2006, Biophysical journal.

[47]  M. Astruc,et al.  Prolonged treatment of breast cancer cells with antiestrogens increases the activating protein-1-mediated response: involvement of the estrogen receptor. , 1995, Endocrinology.

[48]  N. Mantel.  The detection of disease clustering and a generalized regression approach. , 1967, Cancer research.

[49]  M. Bednarek,et al.  1H NMR structural analysis of human ghrelin and its six truncated analogs. , 2001, Biopolymers.

[50]  D. Oprian,et al.  Tertiary interactions between transmembrane segments 3 and 5 near the cytoplasmic side of rhodopsin. , 1999, Biochemistry.

[51]  T. Schwartz,et al.  Molecular mechanism of 7TM receptor activation--a global toggle switch model. , 2006, Annual review of pharmacology and toxicology.

[52]  A. Kukol,et al.  Conformational Flexibility of the Peptide Hormone Ghrelin in Solution and Lipid Membrane Bound: A Molecular Dynamics Study , 2006, Journal of biomolecular structure & dynamics.

[53]  A. Moulin,et al.  Trisubstituted 1,2,4-triazoles as ligands for the ghrelin receptor: on the significance of the orientation and substitution at position 3. , 2008, Bioorganic & medicinal chemistry letters.

[54]  D. Farrens,et al.  Conformational Changes in Rhodopsin , 1999, The Journal of Biological Chemistry.

[55]  C Altenbach,et al.  Structural features and light-dependent changes in the sequence 306-322 extending from helix VII to the palmitoylation sites in rhodopsin: a site-directed spin-labeling study. , 1999, Biochemistry.

[56]  J. Klein-Seetharaman,et al.  Structure and function in rhodopsin: mapping light-dependent changes in distance between residue 316 in helix 8 and residues in the sequence 60-75, covering the cytoplasmic end of helices TM1 and TM2 and their connection loop CL1. , 2001, Biochemistry.

[57]  Jean Martinez,et al.  Regulation of ERK1/2 activity by ghrelin‐activated growth hormone secretagogue receptor 1A involves a PLC/PKCɛ pathway , 2006 .

[58]  S. W. Lin,et al.  Specific tryptophan UV-absorbance changes are probes of the transition of rhodopsin to its active state. , 1996, Biochemistry.

[59]  V. Locatelli,et al.  New trisubstituted 1,2,4-triazole derivatives as potent ghrelin receptor antagonists. 3. Synthesis and pharmacological in vitro and in vivo evaluations. , 2008, Journal of medicinal chemistry.

[60]  T. Schwartz,et al.  Identification of an Efficacy Switch Region in the Ghrelin Receptor Responsible for Interchange between Agonism and Inverse Agonism* , 2007, Journal of Biological Chemistry.

[61]  Patrick Scheerer,et al.  Crystal structure of the ligand-free G-protein-coupled receptor opsin , 2008, Nature.

[62]  D. Underwood,et al.  Structural Requirements for the Activation of the Human Growth Hormone Secretagogue Receptor by Peptide and Nonpeptide Secretagogues , 1997 .

[63]  M. Bednarek,et al.  Structure-function studies on the new growth hormone-releasing peptide, ghrelin: minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a. , 2000, Journal of medicinal chemistry.

[64]  Alan Grossfield,et al.  Convergence of molecular dynamics simulations of membrane proteins , 2007, Proteins.

[65]  T. Schwartz,et al.  Common Structural Basis for Constitutive Activity of the Ghrelin Receptor Family* , 2004, Journal of Biological Chemistry.